Topic
pharmaceutical acquisition
2 stories related to this topic, newest first.
Substrate placeholder — needs reviewscience74 days ago
Merck Announces $6.7 Billion Acquisition of Terns Pharmaceuticals Following Drug Data
Merck announced last month its acquisition of Terns Pharmaceuticals for $6.7 billion. The deal follows promising early data from Terns' experimental leukemia drug. New details have emerged on the pricing negotiations.
ST
Substrate placeholder — needs reviewworld76 days ago
Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics for $2.9 Billion
Neurocrine Biosciences has entered an agreement to purchase Soleno Therapeutics for $2.9 billion in cash. The acquisition aims to broaden Neurocrine's portfolio in treatments for rare genetic disorders. Soleno's lead product, DCCR, targets Prader-Willi syndrome, a rare condition…
BU